Capital Increase in Genmab as a Result of Employee Warrant Exercise
November 11, 2015 12:57 ET
|
Genmab A/S
Company Announcement
Copenhagen, Denmark; November 11, 2015 – Genmab A/S (OMX: GEN) will increase its share capital by 209,133 shares as a consequence of the exercise of employee warrants.
The...
Genmab præsenterer ved Jefferies Autumn 2015 Global Healthcare konference
November 11, 2015 09:24 ET
|
Genmab A/S
Pressemeddelelse
København, Danmark, 11. november 2015 – Genmab A/S (OMX: GEN) har i dag offentliggjort, at selskabets CEO Jan van de Winkel, ph.d., vil give en præsentation om Genmab på...
Genmab to Present at the Jefferies Autumn 2015 Global Healthcare Conference
November 11, 2015 09:24 ET
|
Genmab A/S
Media Release
Copenhagen, Denmark; November 11, 2015 – Genmab A/S (OMX: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will present a company update at the Jefferies Autumn 2015...
Genmab Announces Daratumumab and Ofatumumab Data to Be Presented at American Society of Hematology Annual Meeting (ASH)
November 05, 2015 10:01 ET
|
Genmab A/S
Media Release
19 abstracts on Genmab programs scheduled for presentation at ASH including 3 daratumumab oral presentations and 11 daratumumab poster presentations
Daratumumab highlights:...
Genmab meddeler, at der vil blive præsenteret data vedrørende daratumumab og ofatumumab på årsmødet i American Society of Hematology (ASH)
November 05, 2015 10:01 ET
|
Genmab A/S
Pressemeddelelse
19 abstracts om Genmabs programmer vil blive præsenteret på ASH, herunder 3 mundtlige præsentationer om daratumumab og 11 poster-præsentationer om daratumumab
Daratumumab...
Genmab Announces Financial Results for the First Nine Months of 2015 and Improves 2015 Financial Guidance
November 03, 2015 11:01 ET
|
Genmab A/S
November 3, 2015; Copenhagen, Denmark;
Interim Report for the Nine Months Ended September 30, 2015
Daratumumab granted Priority Review by U.S. Food and Drug Administration (FDA) and...
Genmab offentliggør resultat for de første ni måneder af 2015 og opjusterer forventningerne til 2015
November 03, 2015 11:01 ET
|
Genmab A/S
Bemærk venligst at dette er et uddrag af delårsrapporten, og at den samlede delårsrapport for de første ni måneder af 2015 kun foreligger på engelsk.
3. november 2015: København, Danmark...
Genmab opnår milestonebetaling på USD 3 mio. i samarbejdet med Janssen om DuoBody platformen
October 25, 2015 17:23 ET
|
Genmab A/S
Selskabsmeddelelse
Genmab opnår milestonebetaling på USD 3 mio. i samarbejdet med Janssen om DuoBody® platformen
København, Danmark; 25. oktober 2015 – Genmab A/S (OMX: GEN) har i dag...
Genmab Achieves $3 Million Milestone Payment in DuoBody Platform Collaboration with Janssen
October 25, 2015 17:23 ET
|
Genmab A/S
Company Announcement
Genmab achieves $3 million milestone payment in DuoBody® collaboration with Janssen
Copenhagen, Denmark; October 25, 2015 – Genmab A/S (OMX: GEN) announced today it has...
Major Shareholder Announcement
October 23, 2015 09:30 ET
|
Genmab A/S
Company Announcement
Major shareholder announcement for Genmab A/S
Copenhagen, Denmark; October 23, 2015 – Genmab A/S (OMX: GEN) announces under reference to Section 29 of the Danish...